Advertisement
Advertisement

PLSE

PLSE logo

Pulse Biosciences, Inc Common Stock (DE)

22.05
USD
Sponsored
+0.03
+0.11%
Mar 26, 10:10 UTC -4
Open

PLSE Earnings Reports

Positive Surprise Ratio

PLSE beat 10 of 23 last estimates.

43%

Next Report

Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$408.00K
/
-$0.32
Implied change from Q4 25 (Revenue/ EPS)
+54.55%
/
+23.08%
Implied change from Q1 25 (Revenue/ EPS)
--
/
+88.24%

Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue

On Feb 19, 2026, PLSE reported earnings of -0.26 USD per share (EPS) for Q4 25, beating the estimate of -0.31 USD, resulting in a 17.77% surprise. Revenue reached 264.00 thousand, compared to an expected 255.00 thousand, with a 3.53% difference. The market reacted with a -14.59% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 408.00 thousand USD, implying an increase of 23.08% EPS, and increase of 54.55% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
ClearPoint Neuro, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.26
Surprise
-27.45%
logo
EDAP TMS SA
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.21
Surprise
-65.56%
logo
Hyperfine, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.05
Surprise
+38.73%
logo
Neuronetics, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.09%
logo
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
logo
InspireMD, Inc.
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.14
Surprise
+29.01%
logo
DarioHealth Corp. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$3.30
Actual
-$3.43
Surprise
-3.71%
logo
Spectral AI, Inc. Class A Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.11
Surprise
+14.86%
logo
SiNtx Technologies, Inc. Common Stock
Report Date
Mar 20, 2026 For Q4 25
Estimate
-$0.56
Actual
-$0.56
Surprise
-1.60%
logo
Tenon Medical, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.38
Surprise
-3.49%
FAQ
For Q4 2025, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.26, beating estimates by 17.77%, and revenue of $264.00K, 3.53% above expectations.
The stock price moved down -14.59%, changed from $25.08 before the earnings release to $21.42 the day after.
The next earning report is scheduled for May 06, 2026.
Based on 3 analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.32 and revenue of $408.00K for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement